Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vera Therapeutics Inc Cl A (VERA)

Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vera Therapeutics Inc Cl A 2000 SIERRA POINT PARKWAY SUITE 1200 BRISBANE CA 94005 USA

www.veratx.com Employees: 112 P: 650-770-0077

Sector:

Medical

Description:

Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 3,183,615
Enterprise Value, $K 3,141,655
Shares Outstanding, K 63,928
Annual Sales, $ 0 K
Annual Net Income, $ -152,150 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -80,290 K
EBIT, $ -270,170 K
EBITDA, $ -278,230 K
60-Month Beta 1.21
% of Insider Shareholders 16.30%
% of Institutional Shareholders 99.21%
Float, K 53,508
% Float 83.70%
Short Volume Ratio 0.62

Growth:

1-Year Return 11.65%
3-Year Return 142.81%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.26 on 11/05/25
Next Earnings Date 02/25/26
Earnings Per Share ttm -3.99
EPS Growth vs. Prev Qtr -5.00%
EPS Growth vs. Prev Year -48.24%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 01/29/96
Dividend Payout Ratio 0.00%

VERA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.92%
Return-on-Assets % -42.67%
Profit Margin % 0.00%
Debt/Equity 0.19
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 7.38
Book Value/Share 6.24
Interest Coverage -18.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar